KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medpace Holdings (MEDP) Common Equity (2016 - 2025)

Historic Common Equity for Medpace Holdings (MEDP) over the last 11 years, with Q4 2025 value amounting to $459.1 million.

  • Medpace Holdings' Common Equity fell 4439.18% to $459.1 million in Q4 2025 from the same period last year, while for Dec 2025 it was $459.1 million, marking a year-over-year decrease of 4439.18%. This contributed to the annual value of $459.1 million for FY2025, which is 4439.18% down from last year.
  • Latest data reveals that Medpace Holdings reported Common Equity of $459.1 million as of Q4 2025, which was down 4439.18% from $293.6 million recorded in Q3 2025.
  • Medpace Holdings' Common Equity's 5-year high stood at $952.9 million during Q4 2021, with a 5-year trough of $172.4 million in Q2 2025.
  • Moreover, its 5-year median value for Common Equity was $576.3 million (2023), whereas its average is $580.8 million.
  • In the last 5 years, Medpace Holdings' Common Equity soared by 9526.39% in 2024 and then plummeted by 7742.91% in 2025.
  • Over the past 5 years, Medpace Holdings' Common Equity (Quarter) stood at $952.9 million in 2021, then crashed by 59.45% to $386.4 million in 2022, then surged by 44.66% to $558.9 million in 2023, then skyrocketed by 47.7% to $825.5 million in 2024, then plummeted by 44.39% to $459.1 million in 2025.
  • Its Common Equity was $459.1 million in Q4 2025, compared to $293.6 million in Q3 2025 and $172.4 million in Q2 2025.